ImmuneWatch Featured on QIAGEN Website

QIAGEN, a global leader in sample and assay technologies, has published a customer story featuring ImmuneWatch on their website. The piece explores how ImmuneWatch is tackling one of the longest-standing challenges in systems immunology: predicting T cell receptor specificity using machine learning.

The story highlights how ImmuneWatch DETECT complements QIAseq-derived TCR repertoire data, enabling researchers to extract deeper biological insight from their sequencing results. By annotating the antigen specificity of each T cell receptor in a repertoire, DETECT adds a critical layer of interpretation to standard TCR sequencing workflows.

This feature underscores the growing recognition that combining high-quality sequencing with advanced computational analysis is essential for advancing immuno-monitoring in oncology and vaccine development.